These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11823128)

  • 1. PET studies of 18F-memantine in healthy volunteers.
    Ametamey SM; Bruehlmeier M; Kneifel S; Kokic M; Honer M; Arigoni M; Buck A; Burger C; Samnick S; Quack G; Schubiger PA
    Nucl Med Biol; 2002 Feb; 29(2):227-31. PubMed ID: 11823128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex.
    Samnick S; Ametamey S; Leenders KL; Vontobel P; Quack G; Parsons CG; Neu H; Schubiger PA
    Nucl Med Biol; 1998 May; 25(4):323-30. PubMed ID: 9639292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-18 radiolabelling, biodistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor.
    Ametamey SM; Samnick S; Leenders KL; Vontobel P; Quack G; Parsons CG; Schubiger PA
    J Recept Signal Transduct Res; 1999; 19(1-4):129-41. PubMed ID: 10071753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors.
    Salabert AS; Fonta C; Fontan C; Adel D; Alonso M; Pestourie C; Belhadj-Tahar H; Tafani M; Payoux P
    Nucl Med Biol; 2015 Aug; 42(8):643-53. PubMed ID: 25963911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand.
    Blin J; Denis A; Yamaguchi T; Crouzel C; MacKenzie ET; Baron JC
    Neurosci Lett; 1991 Jan; 121(1-2):183-6. PubMed ID: 1826943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain kinetics of (R)- and (S)-[N-methyl-11C]ketamine in the rhesus monkey studied by positron emission tomography (PET).
    Hartvig P; Valtysson J; Antoni G; Westerberg G; Långström B; Ratti Moberg E; Oye I
    Nucl Med Biol; 1994 Oct; 21(7):927-34. PubMed ID: 9234346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, radiosynthesis, and biological evaluation of fluorinated thienylcyclohexyl piperidine derivatives as potential radiotracers for the NMDA receptor-linked calcium ionophore.
    Ouyang X; Mukherjee J; Yang ZY
    Nucl Med Biol; 1996 Apr; 23(3):315-24. PubMed ID: 8782243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor.
    Waterhouse RN; Slifstein M; Dumont F; Zhao J; Chang RC; Sudo Y; Sultana A; Balter A; Laruelle M
    Nucl Med Biol; 2004 Oct; 31(7):939-48. PubMed ID: 15464396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
    Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
    Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.
    Patel S; Hamill TG; Connolly B; Jagoda E; Li W; Gibson RE
    Nucl Med Biol; 2007 Nov; 34(8):1009-17. PubMed ID: 17998106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.
    Andrée B; Halldin C; Pike VW; Gunn RN; Olsson H; Farde L
    J Nucl Med; 2002 Mar; 43(3):292-303. PubMed ID: 11884487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.
    Kornhuber J; Quack G
    Neurosci Lett; 1995 Aug; 195(2):137-9. PubMed ID: 7478269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride.
    Gründer G; Siessmeier T; Piel M; Vernaleken I; Buchholz HG; Zhou Y; Hiemke C; Wong DF; Rösch F; Bartenstein P
    J Nucl Med; 2003 Jan; 44(1):109-16. PubMed ID: 12515884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, and monkey positron emission tomography (PET) studies of [18F]Y1-973, a PET tracer for the neuropeptide Y Y1 receptor.
    Hostetler ED; Sanabria-Bohórquez S; Fan H; Zeng Z; Gantert L; Williams M; Miller P; O'Malley S; Kameda M; Ando M; Sato N; Ozaki S; Tokita S; Ohta H; Williams D; Sur C; Cook JJ; Burns HD; Hargreaves R
    Neuroimage; 2011 Feb; 54(4):2635-42. PubMed ID: 21078401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.